DiaMedica Therapeutics
DMAC
DMAC
16 hedge funds and large institutions have $6.37M invested in DiaMedica Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.26% more ownership
Funds ownership: 8.47% → 10.73% (+2.3%)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$574K | |
| 3 | +$493K | |
| 4 |
Goldman Sachs
New York
|
+$253K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$173K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$372K | |
| 3 | -$5K | |
| 4 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$5K |